Home  >  Products  >  IRAK4 (interleukin-1 receptor-associated kinase 4 ) Blocking Peptide (the C terminal of IRAK4)(100ug)
IRAK4 (interleukin-1 receptor-associated kinase 4 ) Blocking Peptide (the C terminal of IRAK4)(100ug)

IRAK4 (interleukin-1 receptor-associated kinase 4 ) Blocking Peptide (the C terminal of IRAK4)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IRAK4 Antibody (ARP61431_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61431
Size: 100ug
Weight: 36kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a kinase that activates NF-kappaB in both the Toll-like receptor (TLR) and T-cell receptor (TCR) signaling pathways. The protein is essential for most innate immune responses. Mutations in this gene result in IRAK4 deficiency and recurrent invasive pneumococcal disease. Multiple transcript variants encoding different isoforms have been found for this gene.
Alternative names: IPD1; NY-REN-64; REN64